T
TALMedora Editorial
The biggest cancer meeting on earth just opened and one…
The biggest cancer meeting on earth just opened and one drug has every oncologist holding their breath ASCO 2026 kicks off in Chicago today with 3,000+ studies. The headline: a RAS-blocking drug that could finally crack pancreatic cancer, one of medicine's oldest unsolved problems. Every year, 40,000 oncologists descend on Chicago for the American Society of Clinical Oncology Annual Meeting. This year, May 29 to June 2, one drug is dominating the pre-meeting conversation before a single slide has loaded. Daraxonrasib, developed by Revolution Medicines, targets RAS mutations, the most common oncogen
Create an account to read the full story.
Join TALMedora to get full access
Already have an account?
Comments (0)
No comments yet. Be the first to comment!